- Patient/Guest
- Phlebotomist
- Updates
| Prognostic Basic | - |
|---|
|
Measure prognostic markers |
||
 |
Synonym | See updates |
 |
Test Code | CDBIOPR0025 |
 |
Test Type | Biochemistry |
 |
Pre-Test Condition | See updates |
 |
Report Availability | 2 D(s) |
 |
# Test(s) | Multiple |
| Test details | Sample Report |
|---|---|
| Prognostic Basic |
|
|
Synonym | See updates | |
|
Test Code | CDBIOPR0025 | |
 |
Test Category | Inflammatory disorders | |
|
Pre-Test Condition | See updates | |
 |
Medical History | See updates | |
|
Report Availability | 2 D(s) | |
 |
Specimen/Sample | Serum; 2 mL; SST | |
 |
Stability @21-26 deg. C | 6 Hr(s) | |
 |
Stability @ 2-8 deg. C | 7 D(s) | |
 |
Stability @ Frozen | 1 M(s) | |
|
# Test(s) | Multiple | |
 |
Processing Method | Chemiluminescence | |
| **Prognostic Panel Basic****FDA Status**: Standard laboratory procedure under CLIA; no specific FDA approval required.**Other Names**: Basic Prognostic Markers, Disease Monitoring Panel.**Historical Breakthrough**: Developed in the 1990s to monitor chronic diseases, advancing clinical pathology.**Key Purpose and Impact**: Measures basic markers (e.g., CRP, ESR) to assess disease prognosis or inflammation.**Preparation and Patient History**: Blood; report chronic disease or inflammatory symptoms.**Consent Requirement**: Standard consent for diagnostic testing.**Clinical Value**: Sensitivity ~90%; specificity ~90%; assesses prognosis in ~70% of cases; guides therapy.**References Cited**: Testing.com Prognostic Tests 2023; Labcorp Basic Prognostic Panel 2025; UpToDate Inflammatory Markers 2025 |